The Role of p53 Expression in Patients with RAS/BRAF Wild-Type Metastatic Colorectal Cancer Receiving Irinotecan and Cetuximab as Later Line Treatment.

Auteurs : Ziranu P, Lai E, Schirripa M, Puzzoni M, Persano M, Pretta A, Munari G, Liscia N, Pusceddu V, Loupakis F, Demurtas L, Libertini M, Mariani S, Migliari M, Dubois M, Giampieri R, Sotgiu G, Dei Tos AP, Lonardi S, Zaniboni A, Fassan M, Scartozzi M
Jaar : 2021
Journal : Target Oncol
Volume : 16
Pagina's : 517-527

Salvage stereotactic body radiotherapy (SBRT) for intraprostatic relapse after prostate cancer radiotherapy: An ESTRO ACROP Delphi consensus.

Auteurs : Jereczek-Fossa BA, Marvaso G, Zaffaroni M, Gugliandolo SG, Zerini D, Corso F, Gandini S, Alongi F, Bossi A, Cornford P, De Bari B, Fonteyne V, Hoskin P, Pieters BR, Tree AC, Arcangeli S, Fuller DB, Franzese C, Hannoun-Levi JM, Janoray G, Kerkmeijer L, Kwok Y, Livi L, Loi M, Miralbell R, Pasquier D, Pinkawa M, Scher N, Scorsetti M, Shelan M, Toledano A, van As N, Vavassori A, Zilli T, Pepa M, Ost P
Jaar : 2021
Journal : Cancer Treat Rev
Volume : 98
Pagina's : 102206

State of the art and future directions in the systemic treatment of neuroendocrine neoplasms.

Auteurs : Jungels C, Deleporte A
Jaar : 2021
Journal : Curr Opin Oncol
Volume : 33
Pagina's : 378-385

[Definition and standardization of histocompatibility requests depending on patient course and donor type: Guidelines from the Francophone Society of Bone Marrow Transplantation and Cellular Therapy (SFGM-TC) and the Francophone Society of Histocompa

Auteurs : Dubois V, Amokrane K, Crocchiolo R, Fort M, Guillaume N, Kennel A, Michiels S, Ralazamahaleo M, Rouzaire PO, Yakoub-Agha I, Faucher C
Jaar : 2021
Journal : Bull Cancer
Volume : 108
Pagina's : S45-S52

Luminal Breast Cancer: Risk of Recurrence and Tumor-Associated Immune Suppression.

Auteurs : Pellegrino B, Hlavata Z, Migali C, De Silva P, Aiello M, Willard-Gallo K, Musolino A, Solinas C
Jaar : 2021
Journal : Mol Diagn Ther
Volume : 25
Pagina's : 409-424

Editorial: Radioembolization for metastatic colorectal cancer: towards maturity, at last?

Auteurs : Hendlisz A, Sclafani F
Jaar : 2021
Journal : Curr Opin Oncol
Volume : 33
Pagina's : 351-352

Checkpoint inhibition in combination with an immunoboost of external beam radiotherapy in solid tumors (CHEERS): study protocol for a phase 2, open-label, randomized controlled trial.

Auteurs : Spaas M, Sundahl N, Hulstaert E, Kruse V, Rottey S, De Maeseneer D, Surmont V, Meireson A, Brochez L, Reynders D, Goetghebeur E, Van den Begin R, Van Gestel D, Renard V, Dirix P, Mestdagh P, Ost P
Jaar : 2021
Journal : BMC Cancer
Volume : 21
Pagina's : 514

Immune-Mediated Drug-Induced Liver Injury: Immunogenetics and Experimental Models.

Auteurs : Gerussi A, Natalini A, Antonangeli F, Mancuso C, Agostinetto E, Barisani D, Di Rosa F, Andrade R, Invernizzi P
Jaar : 2021
Journal : Int J Mol Sci
Volume : 22

Malignant Phyllodes Tumor of the Breast: A Practice Review.

Auteurs : Fede ÂBS, Pereira Souza R, Doi M, De Brot M, Aparecida Bueno de Toledo Osorio C, Rocha Melo Gondim G, Casali-da-Rocha JC, Jbili R, Bitencourt AGV, Alves de Souza J, Caparica R, Baroni Alves Makdissi F, Moraes Sanches S
Jaar : 2021
Journal : Clin Pract
Volume : 11
Pagina's : 205-215

Murlentamab, a Low Fucosylated Anti-Müllerian Hormone Type II Receptor (AMHRII) Antibody, Exhibits Anti-Tumor Activity through Tumor-Associated Macrophage Reprogrammation and T Cell Activation.

Auteurs : Prat M, Salon M, Allain T, Dubreuil O, Noël G, Preisser L, Jean B, Cassard L, Lemée F, Tabah-Fish I, Pipy B, Jeannin P, Prost JF, Barret JM, Coste A
Jaar : 2021
Journal : Cancers (Basel)
Volume : 13

Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer: a European study.

Auteurs : Pinato DJ, Scotti L, Gennari A, Colomba-Blameble E, Dolly S, Loizidou A, Chester J, Mukherjee U, Zambelli A, Aguilar-Company J, Bower M, Galazi M, Salazar R, Bertuzzi A, Brunet J, Mesia R, Sita-Lumsden A, Colomba J, Pommeret F, Seguí E, Biello F, Generali D, Grisanti S, Rizzo G, Libertini M, Moss C, Evans JS, Russell B, Wuerstlein R, Vincenzi B, Bertulli R, Ottaviani D, Liñan R, Marrari A, Carmona-García MC, Sng CCT, Tondini C, Mirallas O, Tovazzi V, Fotia V, Cruz CA, Saoudi-Gonzalez N, Felip E, R Lloveras A, Lee AJX, Newsom-Davis T, Sharkey R, Chung C, García-Illescas D, Reyes R, Sophia Wong YN, Ferrante D, Marco-Hernández J, Ruiz-Camps I, Gaidano G, Patriarca A, Sureda A, Martinez-Vila C, Sanchez de Torre A, Rimassa L, Chiudinelli L, Franchi M, Krengli M, Santoro A, Prat A, Tabernero J, V Hemelrijck M, Diamantis N, Cortellini A
Jaar : 2021
Journal : Eur J Cancer
Volume : 150
Pagina's : 190-202

A Phase I Study of an IDO-1 Inhibitor (LY3381916) as Monotherapy and in Combination With an Anti-PD-L1 Antibody (LY3300054) in Patients With Advanced Cancer.

Auteurs : Kotecki N, Vuagnat P, ONeil BH, Jalal S, Rottey S, Prenen H, Benhadji KA, Xia M, Szpurka AM, Saha A, Wallin J, Suriyapperuma S, Galvao VR, Geeganage S, Doman TN, Gandhi L, Xu X, Bendell J
Jaar : 2021
Journal : J Immunother
Volume : 44
Pagina's : 264-275

Nutrition education in medical schools (NEMS) project: Joining ESPEN and university point of view.

Auteurs : Cuerda C, Muscaritoli M, Krznaric Z, Pirlich M, Van Gossum A, Schneider S, Ellegard L, Fukushima R, Chourdakis M, Della Rocca C, Milovanovic D, Lember M, Arias-Diaz J, Stylianidis E, Anastasiadis K, Alunni V, Mars T, Hellerman MI, Irtun O, Abbasoglu O, Barazzoni R
Jaar : 2021
Journal : Clin Nutr
Volume : 40
Pagina's : 2754-2761

Assessment of cough in head and neck cancer patients at risk for dysphagia-An overview.

Auteurs : Mootassim-Billah S, Van Nuffelen G, Schoentgen J, De Bodt M, Dragan T, Digonnet A, Roper N, Van Gestel D
Jaar : 2021
Journal : Cancer Rep (Hoboken)
Pagina's : e1395

RTK Inhibitors in Melanoma: From Bench to Bedside.

Auteurs : Sabbah M, Najem A, Krayem M, Awada A, Journe F, Ghanem G
Jaar : 2021
Journal : Cancers (Basel)
Volume : 13

Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry.

Auteurs : Devos T, Havelange V, Theunissen K, Meers S, Benghiat FS, Gadisseur A, Vanstraelen G, Vellemans H, Bailly B, Granacher N, Lewalle P, De Becker A, Van Eygen K, Janssen M, Triffet A, Vrelust I, Deeren D, Mazure D, Bekaert J, Beck M, Selleslag D
Jaar : 2021
Journal : Ann Hematol
Volume : 100
Pagina's : 1723-1732

The genomic landscape of carcinomas with mucinous differentiation.

Auteurs : Nguyen B, Sanchez-Vega F, Fong CJ, Chatila WK, Boroujeni AM, Pareja F, Weigelt B, Sotiriou C, Larsimont D, Reis-Filho JS, Desmedt C, Schultz N
Jaar : 2021
Journal : Sci Rep
Volume : 11
Pagina's : 9478

Evaluation of the XVI dual registration tool for image-guided radiotherapy in prostate cancer.

Auteurs : Sousa F, Jourani Y, Van den Begin R, Otte FX, Ridai S, Desle M, Ferreira A, Ahmimed R, van Klink-de Goeij MCM, Van Gestel D
Jaar : 2021
Journal : Tech Innov Patient Support Radiat Oncol
Volume : 18
Pagina's : 22-28

Lung cancer screening with low dose computed tomography : a systematic review.

Auteurs : Goudemant C, Durieux V, Grigoriu B, Berghmans T
Jaar : 2021
Journal : Rev Mal Respir
Volume : 38
Pagina's : 489-505

Prostate Cancer and Reactive Haemophagocytic Lymphohistiocytosis.

Auteurs : Dumont L, Salaroli A, Dal Lago L, Gil T, Pepersack T
Jaar : 2021
Journal : Eur J Case Rep Intern Med
Volume : 8
Pagina's : 002425